Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling

Nature Medicine

Volumn 10, Issue 7, 2004, Pages 712-718

  Inoue, Makoto ^a   Rashid, Md Harunor ^a   Fujita, Ryousuke ^a   Contos, James J A ^b   Chun, Jerold ^c   Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Fred Hutchinson Cancer Research Center   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; G PROTEIN COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; PROTEIN KINASE C GAMMA; RHO KINASE;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DORSAL ROOT; GENETIC ANALYSIS; HYPERALGESIA; MALE; MOUSE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPINAL CORD DORSAL HORN; SPINAL GANGLION; WILD TYPE;

ADP RIBOSE TRANSFERASES; ANIMALS; BOTULINUM TOXINS; CALCIUM CHANNELS; HYPERALGESIA; MALE; MICE; MICE, INBRED C57BL; PAIN; PROTEIN KINASE C; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, LYSOPHOSPHATIDIC ACID; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 3142685946     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1060     Document Type: Article

References (46)

1. Bridges, D., Thompson, S.W. & Rice, A.S. Mechanisms of neuropathic pain. Br. J. Anaesth. 87, 12-26 (2001).
2. Woolf, C.J. & Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353, 1959-1964 (1999).
3. Cui, J.G., Holmin, S., Mathiesen, T., Meyerson, B.A. & Linderoth, B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 88, 239-248 (2000).
4. Sommer, C. & Schafers, M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res. 784, 154-162 (1998).
5. Pezet, S., Malcangio, M. & McMahon, S.B. BDNF: a neuromodulator in nociceptive pathways? Brain Res. Brain Res. Rev. 40, 240-249 (2002).
6. Bennett, G.J. Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies? Proc. Natl. Acad. Sci. USA 96, 7737-7738 (1999).
7. Ma, W. & Eisenach, J.C. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur. J. Neurosci. 15, 1037-1047 (2002).
8. Ramer, M.S., Thompson, S.W. & McMahon, S.B. Causes and consequences of sympathetic basket formation in dorsal root ganglia. Pain 6 (Suppl.), S111-S120 (1999).
9. Schumacher, K.A., Classen, H.G. & Spath, M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb. Haemost. 42, 631-640 (1979).
10. Eichholtz, T., Jalink, K., Fahrenfort, I. & Moolenaar, W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 291, 677-680 (1993).
11. Fukushima, N., Ishii, I., Contos, J.J., Weiner, J.A. & Chun, J. Lysophospholipid receptors. Annu. Rev. Pharmacol. Toxicol. 41, 507-534 (2001).
12. Ishii, I., Fukukshima, N., Ye, X. & Chun, J. Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. (in press).
13. Kusaka, S., Kapousta-Bruneau, N., Green, D.G. & Puro, D.G. Serum-induced changes in the physiology of mammalian retinal glial cells: role of lysophosphatidic acid. J. Physiol. 506, 445-458 (1998).
14. Ye, X., Fukushima, N., Kingsbury, M.A. & Chun, J. Lysophosphatidic acid in neural signaling. Neuroreport 13, 2169-2175 (2002).
15. Fukushima, N., Ye, X. & Chun, J. Neurobiology of lysophosphatidic acid signaling. Neuroscientist 8, 540-550 (2002).
16. Kingsbury, M.A., Rehen, S.K., Contos, J.J., Higgins, C.M. & Chun, J. Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6, 1292-1299 (2003).
17. Ishii, I., Contos, J.J., Fukushima, N. & Chun, J. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58, 895-902 (2000).
18. Renback, K., Inoue, M. & Ueda, H. Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice. Neurosci. Lett. 270, 59-61 (1999).
19. Renback, K., Inoue, M., Yoshida, A., Nyberg, F. & Ueda, H. Vzg-1/lysophosphatidic acid-receptor involved in peripheral pain transmission. Brain Res. Mol. Brain Res. 75, 350-354 (2000).
20. Hecht, J.H., Weiner, J.A., Post, S.R. & Chun, J. Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell. Biol. 135, 1071-1083 (1996).
21. Fukushima, N., Kimura, Y. & Chun, J. A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl. Acad. Sci. USA 95, 6151-6156 (1998).
22. Ye, X., Inoue, M. & Ueda, H. Botulinum toxin C3 inhibits hyperalgesia in mice with partial sciatic nerve injury. Jpn. J. Pharmacol. 83, 161-163 (2000).
23. Uehata, M. et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994 (1997).
24. Weiner, J.A. & Chun, J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl. Acad. Sci. USA 96, 5233-5238 (1999).
25. Ueda, H. In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn. J. Pharmacol. 79, 263-268 (1999).
26. Rashid, M.H. et al. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J. Pharmacol. Exp. Ther. 304, 940-948 (2003).
27. Malmberg, A.B. & Basbaum, A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates. Pain 76, 215-222 (1998).
28. Malmberg, A.B., Chen, C., Tonegawa, S. & Basbaum, A.I. Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ. Science 278, 279-283 (1997).
29. Luo, Z.D. et al. Upregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J. Neurosci. 21, 1868-1875 (2001).
30. Luo, Z.D. et al. Injury type-specific calcium channel α2 δ-1 subunit up-regulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J. Pharmacol. Exp. Ther. 303, 1199-1205 (2002).
31. Weiner, J.A., Fukushima, N., Contos, J.J., Scherer, S.S. & Chun, J. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J. Neurosci. 21, 7069-7078 (2001).
32. Brancolini, C. et al. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22. Mol. Biol. Cell 10, 2441-2459 (1999).
33. Pentland, B. & Donald, S.M. Pain in the Guillain-Barre syndrome: a clinical review. Pain 59, 159-164 (1994).
34. Carter, G.T. et al. Neuropathic pain in Charcot-Marie-Tooth disease. Arch. Phys. Med. Rehabil. 79, 1560-1564 (1998).
35. Gillespie, C.S. et al. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26, 523-531 (2000).
36. Hokfelt, T. et al. Neuropeptides-an overview. Neuropharmacology 39, 1337-1356 (2000).
37. Dickinson, T. & Fleetwood-Walker, S.M. VIP and PACAP: very important in pain? Trends Pharmacol. Sci. 20, 324-329 (1999).
38. Lin, Q., Peng, Y.B. & Willis, W.D. Possible role of protein kinase C in the sensitization of primate spinothalamic tract neurons. J. Neurosci. 16, 3026-3034 (1996).
39. Willis, W.D. Role of neurotransmitters in sensitization of pain responses. Ann. NY Acad. Sci. 933, 142-156 (2001).
40. Mao, J., Price, D.D., Phillips, L.L., Lu, J. & Mayer, D.J. Increases in protein kinase C γ immumoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci. Lett. 198, 75-78 (1995).
41. Miletic, V., Bowen, K.K. & Miletic, G. Loose ligation of the rat sciatic nerve is accompanied by changes in the subcellular content of protein kinase C β II and γ in the spinal dorsal horn. Neurosci. Lett. 288, 199-202 (2000).
42. Contos, J.J., Fukushima, N., Weiner, J.A., Kaushal, D. & Chun, J. Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl. Acad. Sci. USA 97, 13384-13389 (2000).
43. Contos, J.J. et al. Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Eg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2). Mol. Cell. Biol. 22, 6921-6929 (2002).
44. Zimmermann, M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110 (1983).
45. Adlkofer, K. et al. Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy. J. Neurosci. 17, 4662-4671 (1997).
46. Inoue, M. et al. In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord. J. Pharmacol. Exp. Ther. 305, 495-501 (2003).